Three gene variants have been identified that may be contributing to the susceptibility of people of African ancestry to develop glaucoma.

A gene therapy – used to treat skin wounds – has improved visual acuity in a 13-year-old boy with cicatrising conjunctivitis due to a

An experimental drug – part of a new class of therapeutics called ‘senolytics’ – is offering a promising new approach to treating diabetic macular

SightGlass Vision has been granted Breakthrough Device designation to its Diffusion Optics Technology (DOT) spectacle lenses from the United States Food and Drug Administration